Home › Mild Cognitive Impairment › California › Irvine
Mild Cognitive Impairment clinical trials in Irvine, CA
6 studies for Mild Cognitive Impairment are looking for participants at sites in and around Irvine (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of LY3439539 in Participants With Alzheimer's Disease
RecruitingPhase 1
- Irvine Clinical Research, Irvine
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Irvine Clinical Research, Irvine
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RecruitingPhase 3
- Irvine Center for Clinical Research, Irvine
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
RecruitingPhase 4
- Progeny Psychiatric Clinic - Irvine, Irvine
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
RecruitingPhase 3
- Irvine Clinical Research, Irvine
Biomarker Exploration in Aging, Cognition and Neurodegeneration
RecruitingPhase 3Healthy volunteers welcome
- University of California, Irvine, Irvine
About Mild Cognitive Impairment
In mild cognitive impairment (MCI), you have more memory and thinking problems than others your age, but they don't interfere with your everyday life.
More about Mild Cognitive Impairment on MedlinePlus
Mild Cognitive Impairment trials in other cities
- New York City, NY24 studies
- Boston, MA23 studies
- Chicago, IL16 studies
- Baltimore, MD14 studies
- Los Angeles, CA12 studies
- Miami, FL12 studies
- San Francisco, CA11 studies
- Atlanta, GA10 studies
- Houston, TX10 studies
- Birmingham, AL10 studies
- Philadelphia, PA10 studies
- Durham, NC9 studies
Other studies in Irvine
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer23 studies
- Cancer (all types)18 studies
- Metastatic Cancer16 studies
- Lung Cancer15 studies
- Ovarian Cancer14 studies
- Prostate Cancer14 studies
- Multiple Myeloma14 studies
- Alzheimer's Disease12 studies
- Head and Neck Squamous Cell Carcinoma11 studies
- Bladder Cancer11 studies
- Colorectal Cancer11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.